Growth & Size Mid-sized UK-based consulting firm (51-200 employees) serving pharmaceutical and biotech clients, suggesting steady client base and potential for scalable service packages across regulatory, development, and medical device projects.

Industry Focus Specializes in translating science into medicinal products and accelerating market access, creating opportunities to offer end-to-end development support, regulatory strategy, and commercialization consulting for pharma/biotech clients.

Global Footprint Multiple office locations in the UK, Ireland, and the US (Cheshire, Cambridgeshire, Dublin, Pennsylvania) enabling cross-border projects and regional business development with multinational clients.

Tech Enablement Utilizes a diverse tech stack (Xero, SAP, Microsoft 365, Squarespace, Canva, Google AdSense/LinkedIn Ads, Sage) indicating readiness for efficient operations, digital marketing, and scalable client management; potential for upsell of integrated software and data analytics services.

Revenue Scope Reported revenue in the $10M–$25M range with a focus on cost-effective expert assistance, presenting opportunities to tier pricing, retainer-based advisory, and expanded offerings for faster milestone achievement in pharma development programs.